Dicentra Inc.   Report issue

For profit Phase 2
Founded: Toronto Canada (2002)

Organization Overview

First Clinical Trial
2010
NCT01176227
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

dicentra | Dicentra Inc.

Active Ingredients

Drugs in Phase 2 Trials (1)

Lactobacillus acidophilus (2 trials)

Drugs in Other Trials (5)

acetylcysteine (mucomyst) (1 trial)

curcumin (1 trial)

echinacea (1 trial)

nicotinamide (1 trial)

palmitoylethanolamide (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Colonic Diseases (Phase 2)

Colonic Diseases, Functional (Phase 2)

Digestive System Diseases (Phase 2)

Gastrointestinal Diseases (Phase 2)

Irritable Bowel Syndrome (Phase 2)

Syndrome (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 4
  • # of Trial APIs: 6